These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9691082)

  • 1. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer.
    Arenberg DA; Keane MP; DiGiovine B; Kunkel SL; Morris SB; Xue YY; Burdick MD; Glass MC; Iannettoni MD; Strieter RM
    J Clin Invest; 1998 Aug; 102(3):465-72. PubMed ID: 9691082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis.
    Numasaki M; Watanabe M; Suzuki T; Takahashi H; Nakamura A; McAllister F; Hishinuma T; Goto J; Lotze MT; Kolls JK; Sasaki H
    J Immunol; 2005 Nov; 175(9):6177-89. PubMed ID: 16237115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.
    Põld M; Zhu LX; Sharma S; Burdick MD; Lin Y; Lee PP; Põld A; Luo J; Krysan K; Dohadwala M; Mao JT; Batra RK; Strieter RM; Dubinett SM
    Cancer Res; 2004 Mar; 64(5):1853-60. PubMed ID: 14996749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis.
    Berta J; Kenessey I; Dobos J; Tovari J; Klepetko W; Jan Ankersmit H; Hegedus B; Renyi-Vamos F; Varga J; Lorincz Z; Paku S; Ostoros G; Rozsas A; Timar J; Dome B
    J Thorac Oncol; 2010 Aug; 5(8):1120-9. PubMed ID: 20581707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CXC chemokine, monokine induced by interferon-gamma, inhibits non-small cell lung carcinoma tumor growth and metastasis.
    Addison CL; Arenberg DA; Morris SB; Xue YY; Burdick MD; Mulligan MS; Iannettoni MD; Strieter RM
    Hum Gene Ther; 2000 Jan; 11(2):247-61. PubMed ID: 10680839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis.
    Keane MP; Belperio JA; Burdick MD; Lynch JP; Fishbein MC; Strieter RM
    Am J Respir Crit Care Med; 2001 Dec; 164(12):2239-42. PubMed ID: 11751193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer.
    Azuma K; Kawahara A; Hattori S; Taira T; Tsurutani J; Watari K; Shibata T; Murakami Y; Takamori S; Ono M; Izumi H; Kage M; Yanagawa T; Nakagawa K; Hoshino T; Kuwano M
    J Thorac Oncol; 2012 May; 7(5):779-89. PubMed ID: 22481237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
    Arenberg DA; Kunkel SL; Polverini PJ; Glass M; Burdick MD; Strieter RM
    J Clin Invest; 1996 Jun; 97(12):2792-802. PubMed ID: 8675690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis.
    Addison CL; Belperio JA; Burdick MD; Strieter RM
    BMC Cancer; 2004 Jun; 4():28. PubMed ID: 15214968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases.
    Arenberg DA; Kunkel SL; Polverini PJ; Morris SB; Burdick MD; Glass MC; Taub DT; Iannettoni MD; Whyte RI; Strieter RM
    J Exp Med; 1996 Sep; 184(3):981-92. PubMed ID: 9064358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
    Keshamouni VG; Arenberg DA; Reddy RC; Newstead MJ; Anthwal S; Standiford TJ
    Neoplasia; 2005 Mar; 7(3):294-301. PubMed ID: 15799829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of the angiogenic phenotype in non-small cell lung cancer.
    McClelland MR; Carskadon SL; Zhao L; White ES; Beer DG; Orringer MB; Pickens A; Chang AC; Arenberg DA
    Am J Respir Cell Mol Biol; 2007 Mar; 36(3):343-50. PubMed ID: 17079777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis.
    Sun H; Chung WC; Ryu SH; Ju Z; Tran HT; Kim E; Kurie JM; Koo JS
    Cancer Prev Res (Phila); 2008 Oct; 1(5):316-28. PubMed ID: 19138976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
    Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
    Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.
    White ES; Strom SR; Wys NL; Arenberg DA
    J Immunol; 2001 Jun; 166(12):7549-55. PubMed ID: 11390510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
    Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
    Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative effects of CXC chemokines in rat hepatocytes in vitro and in vivo.
    Colletti LM; Green M; Burdick MD; Kunkel SL; Strieter RM
    Shock; 1998 Oct; 10(4):248-57. PubMed ID: 9788656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different biomarkers in non-small cell lung cancer in blood vessel invasion.
    Zhang C; Liu Y; Guo S; Zhang J
    Cell Biochem Biophys; 2014 Nov; 70(2):777-84. PubMed ID: 24801771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.
    Tsao MS; Liu N; Nicklee T; Shepherd F; Viallet J
    Clin Cancer Res; 1997 Oct; 3(10):1807-14. PubMed ID: 9815567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.